Hey Guys,
I came across this stock today and after doing an initial analysis, it really does look like a promising opportunity. I want to get a bit more of an understanding before coming to conclusion and was wondering if you have much material to understand the companies operations on a deeper level.
More specifically information in regards to their products, are they all purchased over the counter and does the customer need to get a prescription from a doctor or just need to ask for it?
In term's of operational leverage is there a specific reason it can get away with a 60% GP compared to other distributors and what are the arguments that this can be sustainable over the medium to long term?
Ann: FY24 Revenue Guidance Upgrade to $12.5M, page-13
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 46226 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 83602 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BIO (ASX) Chart |